All In MedTech

Device Trial Radar · NCT06311773

Pivotal Trial of the Boomerang Catheter for pDVA

Pivotal Multicenter Trial of the Boomerang® Catheter for Percutaneous Deep Vein Arterialization (pDVA)

Last checked: Nov 20, 2026Latest source record: Jul 24, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Enrolling by invitationPivotal-lookingTitle says "pivotal". This is a heuristic, not a regulatory label.

Status

Enrolling by invitation

Enrollment

120

Planned (sponsor's estimate)

Start

Apr 16, 2024

Primary completion

Mar 31, 2027

Study completion Mar 31, 2030

Sponsor

Lead sponsor
Aveera Medical, Inc.Not on our public-company list
Sponsor type
Industry
First posted
Mar 15, 2024

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to establish the safety and effectiveness of the Boomerang Catheter for percutaneous Deep Venous Arterialization (pDVA) to treat no-option Chronic Limb-Threatening Ischemia.

Conditions

  • Chronic Limb-Threatening Ischemia

Interventions

  • Boomerang CatheterDevice

    The study device used for this procedure makes an anastomosis between a tibial vein and a tibial artery to direct blood flow around blocked arteries.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Amputation Free Survival (AFS)Time frame: 6-months

Locations

25 sites in 1 country. Site status is shown where the registry gives one.

  • Arrowhead Regional Medical Center

    San Bernardino, California

24 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.